Bryan A. Ward

1.7k total citations · 1 hit paper
8 papers, 1.4k citations indexed

About

Bryan A. Ward is a scholar working on Pharmacology, Infectious Diseases and Genetics. According to data from OpenAlex, Bryan A. Ward has authored 8 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Infectious Diseases and 3 papers in Genetics. Recurrent topics in Bryan A. Ward's work include Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Bryan A. Ward is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Bryan A. Ward collaborates with scholars based in United States and Germany. Bryan A. Ward's co-authors include David A. Flockhart, Zeruesenay Desta, Nadia Soukhova, David R. Jones, J. Christopher Gorski, Stephen D. Hall, Tanja Saußele, Kathrin Klein, Ulrich M. Zanger and Julia Blievernicht and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Bryan A. Ward

8 papers receiving 1.3k citations

Hit Papers

The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of ... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
    2003 502 citations Bryan A. Ward, J. Christopher Gorski et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan A. Ward United States 7 677 450 392 392 252 8 1.4k
Tanja Saußele Germany 9 606 0.9× 454 1.0× 316 0.8× 65 0.2× 268 1.1× 13 1.1k
M B Faletto United States 11 621 0.9× 407 0.9× 324 0.8× 36 0.1× 247 1.0× 18 1.4k
Gondi Kumar United States 24 654 1.0× 826 1.8× 894 2.3× 45 0.1× 523 2.1× 53 2.5k
Kristina Campanale United States 10 300 0.4× 250 0.6× 175 0.4× 43 0.1× 131 0.5× 17 1.1k
Matthew Wright United States 25 284 0.4× 171 0.4× 352 0.9× 34 0.1× 104 0.4× 85 1.8k
John Tjia United Kingdom 17 332 0.5× 725 1.6× 203 0.5× 24 0.1× 452 1.8× 23 1.3k
Rosa I. Sánchez United States 22 133 0.2× 458 1.0× 105 0.3× 57 0.1× 303 1.2× 50 1.4k
Joy A. Nishime United States 11 316 0.5× 229 0.5× 283 0.7× 25 0.1× 140 0.6× 14 690
M R Boyd United Kingdom 22 328 0.5× 248 0.6× 270 0.7× 124 0.3× 74 0.3× 35 1.6k
Manoli Vourvahis United States 21 334 0.5× 502 1.1× 444 1.1× 20 0.1× 262 1.0× 55 1.4k

Countries citing papers authored by Bryan A. Ward

Since Specialization
Citations

This map shows the geographic impact of Bryan A. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan A. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan A. Ward more than expected).

Fields of papers citing papers by Bryan A. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan A. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan A. Ward. The network helps show where Bryan A. Ward may publish in the future.

Co-authorship network of co-authors of Bryan A. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan A. Ward. A scholar is included among the top collaborators of Bryan A. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan A. Ward. Bryan A. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kamdem, Landry K., Yong Liu, Vered Stearns, et al.. (2010). In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. British Journal of Clinical Pharmacology. 70(6). 854–869. 60 indexed citations
2.
Desta, Zeruesenay, Tanja Saußele, Bryan A. Ward, et al.. (2007). Impact of CYP2B6 Polymorphism on Hepatic Efavirenz Metabolismin Vitro. Pharmacogenomics. 8(6). 547–558. 183 indexed citations
3.
Ward, Bryan A., Zeruesenay Desta, Tonya J. Roberts, et al.. (2005). Diindolylmethane inhibits indoleamine 2,3-dioxygenase activity in breast cancer cells. Cancer Research. 65. 577–577. 1 indexed citations
4.
Ward, Bryan A., et al.. (2004). Characterization of human cytochrome P450 enzymes catalyzing domperidone N‐dealkylation and hydroxylation in vitro. British Journal of Clinical Pharmacology. 58(3). 277–287. 44 indexed citations
5.
Desta, Zeruesenay, Bryan A. Ward, Nadia Soukhova, & David A. Flockhart. (2004). Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6. Journal of Pharmacology and Experimental Therapeutics. 310(3). 1062–1075. 492 indexed citations
6.
7.
Ward, Bryan A., J. Christopher Gorski, David R. Jones, et al.. (2003). The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity. Journal of Pharmacology and Experimental Therapeutics. 306(1). 287–300. 502 indexed citations breakdown →
8.
Dickerman, Robert W., et al.. (1971). Ecologic Studies of Venezuelan Encephalitis Virus in Southeastern México. American Journal of Tropical Medicine and Hygiene. 20(6). 969–979. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanja Saußele Breakdown of academic impact, for papers by M B Faletto Breakdown of academic impact, for papers by Gondi Kumar Breakdown of academic impact, for papers by Kristina Campanale Breakdown of academic impact, for papers by Matthew Wright Breakdown of academic impact, for papers by John Tjia Breakdown of academic impact, for papers by Rosa I. Sánchez Breakdown of academic impact, for papers by Joy A. Nishime Breakdown of academic impact, for papers by M R Boyd Breakdown of academic impact, for papers by Manoli Vourvahis
Rankless by CCL
2026